Daktronics Inc /Sd/
DAKT Nasdaq Miscellaneous Manufacturing Industries Financials FY2017βFY2026
What Daktronics Inc /Sd/ does
No business description yet.
- Legal name
- DAKTRONICS INC /SD/
- Fiscal year ends
- May 2, 2026
- Latest annual report
- 10-K Β· Jun 24, 2026
- Accession Β· CIK
- 0001628280-26-045262
0000915779
Revenue and margins
Daktronics Inc /Sd/ had $839M of revenue in fiscal 2026, up 10.9% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 16.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $34.3M in fiscal 2026, 4.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Daktronics Inc /Sd/ returned $25.6M to shareholders in fiscal 2026, 75% of free cash flow. The diluted share count rose 3.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Daktronics Inc /Sd/ can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $21.2M | $24.5M | $81.3M | $128M | $132M |
| Debt incl. finance leases | β | $17.8M | $54.7M | $12.0M | $10.8M |
| Net debt / EBITDA | β | β0.2x | β0.3x | β2.2x | β1.5x |
| Debt / equity | β | 0.1x | 0.2x | 0.0x | 0.0x |
| Interest coverage | 82.6x | 19.0x | 25.6x | 11.5x | 41.6x |
| Current ratio | 1.5x | 1.6x | 2.1x | 2.2x | 2.3x |
| Quick ratio | 0.9x | 0.9x | 1.4x | 1.6x | 1.7x |
| Total assets | $441M | $468M | $528M | $503M | $554M |
| Total liabilities | $249M | $267M | $289M | $231M | $254M |
| Shareholders' equity | $192M | $201M | $239M | $272M | $301M |
| Net debt (β = net cash) | β | β$6.8M | β$26.6M | β$116M | β$121M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 2 / 8 | 5 / 8 | 7 / 8 | 2 / 8 | 7 / 8 | 6 / 9 | 4 / 9 | 8 / 9 |
| Accruals ratio | β8.2% | β6.9% | β8.6% | β2.9% | β14.8% | 6.8% | β1.8% | β5.7% | β20.9% | β0.7% |
| Altman Z'' | 5.01 | 4.92 | 4.25 | 3.56 | 4.33 | 3.13 | 3.67 | 5.43 | 5.24 | 6.01 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $587M | $611M | $570M | $609M | $482M | $611M | $754M | $818M | $756M | $839M |
| Gross profit | $140M | $146M | $130M | $139M | $121M | $117M | $151M | $222M | $195M | $229M |
| Research and development | $29.1M | $35.5M | $35.6M | $37.8M | $26.8M | $29.0M | $30.0M | $35.7M | $38.9M | $43.5M |
| Operating income | $15.4M | $12.5M | β$4.7M | β$0.2M | $17.1M | $4.0M | $21.4M | $87.1M | $33.1M | $60.8M |
| Interest expense | $0.2M | $0.2M | $0.2M | $0.1M | $0.3M | $0.0M | $1.1M | $3.4M | $2.9M | $1.5M |
| Pretax income | $15.6M | $12.4M | β$4.9M | β$0.0M | $14.1M | $1.1M | $13.3M | $54.1M | β$5.9M | $58.3M |
| Income tax | $5.2M | $6.9M | β$4.0M | β$0.5M | $3.1M | $0.5M | $6.5M | $19.4M | $4.3M | $13.0M |
| Net income | $10.3M | $5.6M | β$1.0M | $0.5M | $10.9M | $0.6M | $6.8M | $34.6M | β$10.1M | $45.4M |
| Diluted EPS | $0.23 | $0.12 | β$0.02 | $0.01 | $0.24 | $0.01 | $0.15 | $0.74 | β$0.21 | $0.92 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $39.4M | $30.4M | $29.5M | $10.8M | $66.2M | β$27.0M | $15.0M | $63.2M | $97.7M | $49.2M |
| Capital expenditure | $8.5M | $18.1M | $17.3M | $18.1M | $7.9M | $20.4M | $25.4M | $17.0M | $19.5M | $14.9M |
| Free cash flow | $30.9M | $12.2M | $12.3M | β$7.3M | $58.3M | β$47.4M | β$10.4M | $46.3M | $78.2M | $34.3M |
| Depreciation and amortization | $19.4M | $17.8M | $18.6M | $17.7M | $17.1M | $15.4M | $17.0M | $19.3M | $19.5M | $19.3M |
| Stock-based compensation | $2.9M | $2.6M | $2.5M | $2.3M | $2.1M | $2.0M | $2.0M | $2.1M | $2.9M | $4.9M |
| Acquisitions | $0.0M | $0.0M | $2.3M | $0.0M | $0.0M | β | β | β | β | β |
| Share buybacks | $1.8M | $0.0M | $0.0M | $5.6M | $0.0M | $3.2M | $0.0M | $0.0M | $29.5M | $25.6M |
| Dividends paid | $13.7M | $12.4M | $12.6M | $9.0M | $0.0M | $0.0M | β | β | β | β |
| Dividends and buybacks | $15.5M | $12.4M | $12.6M | $14.6M | $0.0M | $3.2M | $0.0M | $0.0M | $29.5M | $25.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $32.6M | $29.7M | $35.4M | $41.6M | $77.6M | $21.2M | $24.5M | $81.3M | $128M | $132M |
| Total debt | β | β | β | β | β | β | $17.8M | $54.7M | $12.0M | $10.8M |
| Current assets | $258M | $264M | $254M | $252M | $265M | $318M | $343M | $402M | $381M | $448M |
| Current liabilities | $131M | $131M | $134M | $146M | $147M | $214M | $210M | $192M | $172M | $194M |
| Inventory | $66.5M | $75.3M | $78.8M | $86.8M | $74.4M | $134M | $149M | $138M | $106M | $110M |
| Property and equipment, net | $66.7M | $68.1M | $65.3M | $67.5M | $58.7M | $66.8M | $72.1M | $71.8M | $73.9M | $64.3M |
| Goodwill | $7.8M | $8.3M | $7.9M | $7.7M | $8.4M | $7.9M | $3.2M | $3.2M | $3.2M | $3.7M |
| Intangible assets | $4.7M | $3.7M | $4.9M | $3.4M | $2.1M | $1.5M | $1.1M | $0.8M | $0.6M | $3.3M |
| Total assets | $355M | $359M | $349M | $373M | $375M | $441M | $468M | $528M | $503M | $554M |
| Total liabilities | $157M | $161M | $162M | $196M | $182M | $249M | $267M | $289M | $231M | $254M |
| Preferred stock | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $198M | $198M | $188M | $177M | $194M | $192M | $201M | $239M | $272M | $301M |
| Margins | ||||||||||
| Gross margin | 23.9% | 23.9% | 22.9% | 22.8% | 25.0% | 19.1% | 20.1% | 27.2% | 25.8% | 27.3% |
| Operating margin | 2.6% | 2.0% | β0.8% | β0.0% | 3.5% | 0.7% | 2.8% | 10.6% | 4.4% | 7.3% |
| EBITDA margin | 5.9% | 5.0% | 2.4% | 2.9% | 7.1% | 3.2% | 5.1% | 13.0% | 7.0% | 9.6% |
| Net margin | 1.8% | 0.9% | β0.2% | 0.1% | 2.3% | 0.1% | 0.9% | 4.2% | β1.3% | 5.4% |
| FCF margin | 5.3% | 2.0% | 2.2% | β1.2% | 12.1% | β7.8% | β1.4% | 5.7% | 10.3% | 4.1% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | 7.2% | 26.7% | 16.7% | 26.3% |
| Return on capital employed | 6.9% | 5.5% | β2.2% | β0.1% | 7.5% | 1.8% | 8.3% | 26.0% | 10.0% | 16.9% |
| Return on equity | 5.2% | 2.8% | β0.5% | 0.3% | 5.9% | 0.3% | 3.5% | 15.7% | β4.0% | 15.8% |
| Return on assets | 2.9% | 1.6% | β0.3% | 0.1% | 2.9% | 0.1% | 1.5% | 7.0% | β2.0% | 8.6% |
| Return on tangible equity | 5.6% | 3.0% | β0.5% | 0.3% | 6.0% | 0.3% | 3.5% | 14.7% | β3.8% | 15.4% |
| Growth | ||||||||||
| Revenue growth | β | 4.1% | β6.7% | 6.9% | β20.8% | 26.7% | 23.4% | 8.5% | β7.5% | 10.9% |
| Net income growth | β | β46.2% | β117.2% | β | 2,125.3% | β94.6% | 1,049.0% | 409.0% | β129.2% | β |
| EPS growth | β | β47.8% | β116.7% | β | 2,300.0% | β95.8% | 1,400.0% | 393.3% | β128.4% | β |
| FCF growth | β | β60.4% | 0.4% | β159.3% | β | β181.3% | β | β | 69.1% | β56.1% |
| Share count change | β | 1.3% | 0.1% | 0.9% | β0.3% | 0.3% | 0.4% | 2.2% | 2.2% | 3.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β0.2x | β0.3x | β2.2x | β1.5x |
| Debt / equity | β | β | β | β | β | β | 0.1x | 0.2x | 0.0x | 0.0x |
| Interest coverage | 67.0x | 57.4x | β29.6x | β1.6x | 58.0x | 82.6x | 19.0x | 25.6x | 11.5x | 41.6x |
| Current ratio | 2.0x | 2.0x | 1.9x | 1.7x | 1.8x | 1.5x | 1.6x | 2.1x | 2.2x | 2.3x |
| Quick ratio | 1.5x | 1.4x | 1.3x | 1.1x | 1.3x | 0.9x | 0.9x | 1.4x | 1.6x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.4% | 3.0% | 3.0% | 3.0% | 1.6% | 3.3% | 3.4% | 2.1% | 2.6% | 1.8% |
| Stock comp / revenue | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.4% | 0.6% |
| Payouts / FCF | 50.1% | 101.6% | 102.2% | β | 0.0% | β | β | 0.0% | 37.7% | 74.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 2.0 | 5.0 | 7.0 | 2.0 | 7.0 | 6.0 | 4.0 | 8.0 |
| Altman Z'' | 5.0 | 4.9 | 4.2 | 3.6 | 4.3 | 3.1 | 3.7 | 5.4 | 5.2 | 6.0 |
| Accruals ratio | β8.2% | β6.9% | β8.6% | β2.9% | β14.8% | 6.8% | β1.8% | β5.7% | β20.9% | β0.7% |
Source: SEC EDGAR XBRL filings (CIK 0000915779). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.